These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25936985)

  • 21. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
    Engert A; Haverkamp H; Kobe C; Markova J; Renner C; Ho A; Zijlstra J; Král Z; Fuchs M; Hallek M; Kanz L; Döhner H; Dörken B; Engel N; Topp M; Klutmann S; Amthauer H; Bockisch A; Kluge R; Kratochwil C; Schober O; Greil R; Andreesen R; Kneba M; Pfreundschuh M; Stein H; Eich HT; Müller RP; Dietlein M; Borchmann P; Diehl V; ; ;
    Lancet; 2012 May; 379(9828):1791-9. PubMed ID: 22480758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostics, prognosis factors, and treatment of malignant lymphoproliferative disease, Hodgkin Disease].
    Sivkovich SO; Kysel'ova OA
    Lik Sprava; 2012; (1-2):56-63. PubMed ID: 23035600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
    Chiusolo P; Sica S; Leone G
    Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of early and intermediate stage Hodgkin's lymphoma in the German Hodgkin's Lymphoma Study Group.
    Wiedenmann S; Schiller P; Paulus U; Wolf J
    Ann Oncol; 2002; 13 Suppl 1():84-5. PubMed ID: 12078909
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma.
    Araf S; Montoto S
    Future Oncol; 2013 Jun; 9(6):807-15. PubMed ID: 23718301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography / computerized tomography evaluation of primary Hodgkin's disease of liver.
    Gota VS; Purandare NC; Gujral S; Shah S; Nair R; Rangarajan V
    Indian J Cancer; 2009; 46(3):237-9. PubMed ID: 19574678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report of satellite workshop on interim-PET in Hodgkin lymphoma: 8th International Symposium on Hodgkin Lymphoma, Cologne, 23 October 2010.
    Gallamini A; O'Doherty M
    Leuk Lymphoma; 2011 Apr; 52(4):583-6. PubMed ID: 21438829
    [No Abstract]   [Full Text] [Related]  

  • 28. Staging, response to therapy, and restaging of lymphomas with 18F-FDG PET.
    Altamirano J; Esparza JR; de la Garza Salazar J; Calvo PS; Vera SR; Chalapud Revelo JR; Estrada G
    Arch Med Res; 2008 Jan; 39(1):69-77. PubMed ID: 18067998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers.
    Biggi A; Gallamini A; Chauvie S; Hutchings M; Kostakoglu L; Gregianin M; Meignan M; Malkowski B; Hofman MS; Barrington SF
    J Nucl Med; 2013 May; 54(5):683-90. PubMed ID: 23516309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.
    Rigacci L; Castagnoli A; Dini C; Carpaneto A; Matteini M; Alterini R; Carrai V; Nassi L; Bernardi F; Pieroni C; Bosi A
    Oncol Rep; 2005 Nov; 14(5):1209-14. PubMed ID: 16211287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma.
    Cerci JJ; Pracchia LF; Linardi CC; Pitella FA; Delbeke D; Izaki M; Trindade E; Soares J; Buccheri V; Meneghetti JC
    J Nucl Med; 2010 Sep; 51(9):1337-43. PubMed ID: 20720036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma.
    Agrawal K; Mittal BR; Bansal D; Varma N; Srinivasan R; Trehan A; Manohar K; Kashyap R; Bhattacharya A; Marwaha RK
    Ann Nucl Med; 2013 Feb; 27(2):146-51. PubMed ID: 23143537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is [(18)F]fluorodeoxyglucose positron emission tomography the ultimate tool for response and prognosis assessment?
    Brepoels L; Stroobants S
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):855-69. PubMed ID: 17908624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations].
    Wickmann L; Lüders H; Dörffel W
    Klin Padiatr; 2003; 215(3):146-50. PubMed ID: 12778354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography scanning: a new paradigm for the management of Hodgkin's lymphoma.
    Gallamini A
    Haematologica; 2010 Jul; 95(7):1046-8. PubMed ID: 20595100
    [No Abstract]   [Full Text] [Related]  

  • 37. Positron emission tomography in the management of Hodgkin lymphoma.
    Connors JM
    Hematology Am Soc Hematol Educ Program; 2011; 2011():317-22. PubMed ID: 22160052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET.
    Fanti S; Castellucci P; Stefoni V; Nanni C; Tani M; Rubello D; Ambrosini V; Zinzani PL; Franchi R
    Ann Nucl Med; 2008 Jun; 22(5):429-32. PubMed ID: 18600422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas.
    Kostakoglu L
    Clin Lymphoma Myeloma; 2008 Oct; 8(5):273-6. PubMed ID: 18854280
    [No Abstract]   [Full Text] [Related]  

  • 40. Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: a report of two cases.
    Molin D; Hagberg H; Suurküla M; Aström G
    Acta Oncol; 2010 May; 49(4):526-8. PubMed ID: 20397779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.